Aortic valve stenosis” is an often-overlooked condition and a growing health concern in ageing societies such as Thailand.

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence ...

by self-expanding or balloon-expanding [valve type], or the extent of aortic valve calcification,” said BHF PROTECT-TAVI lead investigator Rajesh Kharbanda, MBChB, PhD (Oxford University Hospitals NHS ...

Valve has released a massive Year in Review highlighting all of its achievements in 2024. It's a big document, and it's not all gripping reading, but one thing that stands out is its details on ...